???-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
Comment
Favorite

jamiengan
2021-08-19

???

恒瑞医药：上半年实现净利润26.68亿元同比增长0.21%

投资研报【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）揭秘：1个月暴涨60%！为什么东方证券能成为龙一？【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>> 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张熠

恒瑞医药：上半年实现净利润26.68亿元同比增长0.21%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":838324219,"tweetId":"838324219","gmtCreate":1629376524131,"gmtModify":1676530020166,"author":{"id":3569299384564621,"authorId":3569299384564621,"authorIdStr":"3569299384564621","name":"jamiengan","avatar":"https://static.tigerbbs.com/889f4395dbbcc2004e91811498c78b43","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>???</p></body></html>","htmlText":"<html><head></head><body><p>???</p></body></html>","text":"???","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/838324219","repostId":2160763716,"repostType":2,"repost":{"id":"2160763716","pubTimestamp":1629364980,"share":"https://www.laohu8.com/m/news/2160763716?lang=&edition=full","pubTime":"2021-08-19 17:23","market":"sh","language":"zh","title":"恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2160763716","media":"新浪财经","summary":"投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n \n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张熠","content":"<html><body><div>\n<blockquote>\n<p>投资研报</p>\n<p>【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）</p>\n<p>牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）</p>\n<p>揭秘：1个月暴涨60%！为什么<a href=\"https://laohu8.com/S/600958\">东方证券</a>能成为龙一？</p>\n<p>【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）</p>\n</blockquote><p>　　8月19日消息，<span><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></span><span></span>：上半年实现净利润26.68亿元，同比增长0.21%。</p>\n<div> </div>\n<div>\n<span>股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿&gt;&gt;</span>\n<img src=\"\"/>\n</div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在<a href=\"https://laohu8.com/S/SINA\">新浪</a>财经APP</div>\n</div>\n<p>责任编辑：张熠 </p>\n</div></body></html>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 17:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","relate_stocks":{"600276":"恒瑞医药"},"source_url":"https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2160763716","content_text":"投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n \n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张熠","news_type":1},"isVote":1,"tweetType":1,"viewCount":106,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}